T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
Keywords
Disease modifying therapies
T-lymphocyte, peptides
Stimulation
Interferon-gamma
IGRA
CD20
Cited by (0)
© 2021 Published by Elsevier B.V.